IFF Reports First Quarter 2019 Results
Achieved double-digit sales growth; Reconfirms full year guidance
First Quarter 2019 Consolidated Summary:
Reported |
Adjusted |
||||||||||||||
Sales |
Operating |
EPS | Sales |
Operating |
EPS |
EPS |
|||||||||
Consolidated | $1.3 B | $164 M | $0.96 | $1.3 B | $205 M | $1.24 | $1.57 | ||||||||
¹ Schedules at the end of this release contain reconciliations of reported GAAP to non-GAAP metrics.
Management Commentary
“Our first quarter results were in line with our expectations and reflect strong progress in the company’s transformation following the Frutarom acquisition,” said Andreas Fibig, IFF Chairman and CEO. “In the first quarter of 2019, we achieved solid sales growth across all three of our divisions and maintained strong profitability levels despite the continued higher raw material cost environment. On a consolidated basis, the combination of our legacy business performance, plus the addition of Frutarom, yielded double-digit sales and adjusted operating profit growth.
“We are executing well against our integration roadmap. For those
businesses where we have aligned our go-to-market approach with IFF –
North America Taste and IBR – growth is very strong, increasing
double-digits. We are also seeing great progress from procurement
synergies and are well underway in terms of our manufacturing
optimization plan. For 2019, we are confident that we will achieve our
“Looking forward, we expect sales growth and profitability to improve in the second half of the year. We remain focused on executing our strategy and integrating successfully, and by doing so, we have reiterated our full year financial guidance.”
First Quarter 2019 Consolidated Financial Results
-
Reported net sales for the first quarter totaled
$1.3 billion , an increase of 39% from$931.0 million in 2018, including the contribution of sales related to Frutarom. On a combined basis, currency neutral sales improved 3%, excluding the contribution of acquisitions and divested businesses, with growth across all segments. -
Reported earnings per share (EPS) for the first quarter was
$0.96 per diluted share versus$1.63 per diluted share reported in 2018. Excluding those items that affect comparability, adjusted EPS ex amortization was$1.57 per diluted share in 2019 versus$1.78 in the year-ago period as adjusted operating profit growth was more than offset by higher interest expense and shares outstanding, both related to the Frutarom acquisition.
First Quarter 2019 Segment Summary: Growth vs. Prior Year
Reported (GAAP) | Currency Neutral (Non-GAAP) | ||||||||
Sales | Segment Profit | Sales | Segment Profit | ||||||
Scent | 1% | (8)% | 4% | (3)% | |||||
Taste | (1)% | (3)% | 2% | (1)% | |||||
Frutarom | - | - | - | - | |||||
Scent Business Unit
-
On a reported basis, sales increased 1%, or
$6.4 million , to$488.4 million . Currency neutral sales improved 4%, with growth in nearly all regions and categories. Performance was strongest in Fine Fragrances, increasing double-digits, led by strong new win performance. Consumer Fragrances grew mid-single digits, with the strongest growth in Home Care and Fabric Care. Fragrance Ingredients was challenged as price increases related to higher raw material costs were more than offset by volume declines. - Scent segment profit decreased 8% on a reported and 3% on a currency neutral basis as the benefits from cost and productivity initiatives were more than offset by unfavorable price to input costs.
Taste Business Unit
-
On a reported basis, sales decreased 1%, or
$4.4 million , to$444.6 million . Currency neutral sales improved 2%, with growth in three of four regions. Performance in the quarter was driven by mid-single digit growth inGreater Asia , whereIndia andIndonesia grew double-digits, and EAME, led by strong growth inAfrica and theMiddle East as well asWestern Europe . InNorth America , year-over-year improvements continue to be led by TastePoint.Latin America declined primarily due to volumes with multinational customers. - Taste segment profit decreased 3% on a reported basis and 1% on a currency neutral basis, as volume growth and the benefits from productivity initiatives were more than offset by unfavorable price to raw material costs and mix.
Frutarom Business Unit
-
On a reported basis, sales were
$364.4 million . On a standalone basis, currency neutral sales grew 3%, excluding the contribution of acquisitions and divested businesses. Performance was driven by strong growth in Taste, led by double-digit gains inNorth America , and solid increases in Savory Solutions, which more than offset declines in F&F ingredients and Natural Colors. -
Segment profit contributed
$29 million in the first quarter;$68 million excluding amortization. Margin performance continued to be driven by disciplined cost management.
The Company reconfirms its 2019 guidance as follows:
Guidance | |||
Sales | $5.2B - $5.3B | ||
Adjusted EPS (1) | $4.90 - $5.10 | ||
Adjusted EPS ex amortization (1) | $6.30 - $6.50 | ||
1 See Use of Non-GAAP Financial Measures
A copy of the Company’s Quarterly Report on Form 10-Q will be available
on its website at www.iff.com
or at www.sec.gov
by
Audio Webcast
A live webcast to discuss the Company’s first quarter 2019 financial
results will be held on
Cautionary Statement Under The Private Securities Litigation Reform Act of 1995
This press release includes “forward-looking statements” under the
Federal Private Securities Litigation Reform Act of 1995, including
statements regarding guidance for full year 2019, expected impact of the
acquisition of Frutarom, including cost savings, and our ability to
accelerate growth and profitability in 2019. These forward-looking
statements are qualified in their entirety by cautionary statements and
risk factor disclosures contained in the Company’s
Use of Non-GAAP Financial Measures
We provide in this press release non-GAAP financial measures, including:
(i) currency neutral sales, which eliminates the effects that result
from translating our international sales in U.S. dollars; (ii) adjusted
operating profit and adjusted EPS, which exclude restructuring costs and
other significant items of a non-recurring and/or non-operational nature
such as gains on sale of assets, operational improvement initiatives,
integration related costs,
These non-GAAP measures are intended to provide additional information regarding our underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. In discussing our historical and expected future results and financial condition, we believe it is meaningful for investors to be made aware of and to be assisted in a better understanding of, on a period-to-period comparable basis, financial amounts both including and excluding these identified items, as well as the impact of exchange rate fluctuations. With respect to the redemption value adjustment to EPS, the Company excluded this adjustment as (i) the amount is not believed to be a measure of earnings and is excluded from the net income attributable to IFF; and (ii) the Company believes that investors may benefit from an understanding of the Company’s results without giving effect to this adjustment. These non-GAAP measures should not be considered in isolation or as substitutes for analysis of the Company’s results under GAAP and may not be comparable to other companies’ calculation of such metrics.
When we provide our expectations for adjusted EPS and adjusted EPS ex amortization for our full year 2019 guidance, the closest corresponding GAAP measure and a reconciliation of the differences between the non-GAAP expectation and the corresponding GAAP measure is not available without unreasonable effort due to length of the forecasted period and potential variability, complexity and low visibility as to items such as future contingencies and other costs that would be excluded from the GAAP measure, and the tax impact of such items, in the relevant future period. The variability of the excluded items may have a significant, and potentially unpredictable, impact on our future GAAP results.
In the fourth quarter of fiscal year 2018, we began including Adjusted (Non-GAAP) EPS ex. Amortization as a key non-GAAP financial measure of our business. Full amortization expense of intangible assets acquired in connection with acquisitions will be excluded from Adjusted (Non-GAAP) EPS ex. Amortization calculation. The exclusion of amortization expense allows comparison of operating results that are consistent over time for newly and long-held businesses and with both acquisitive and non-acquisitive peer companies. We believe this calculation will provide a more accurate presentation in this and in future periods in the event of additional acquisitions. Further, this allows the investors to evaluate and understand operating trends excluding the impact on operating income and earnings per diluted share. In addition, the Frutarom acquisition related costs have been separated from costs related to prior acquisitions. The Frutarom acquisition costs represent a significant balance and we believe this amount should be shown separately to provide an accurate presentation of the acquisition related costs. Our GAAP results and GAAP metrics do not change, and this change has no effect on day to day business operations, or how we manage our business. For Frutarom, we present segment profit excluding amortization expense as it allows comparison of operating results that are consistent over time for newly and long-held businesses and with both acquisitive and non-acquisitive peer companies.
We calculated “combined” numbers by combining (i) our results (including
Frutarom from
Meet IFF
International Flavors & Fragrances Inc. Consolidated Income Statement (Amounts in thousands except per share data) (Unaudited) |
||||||
Three Months Ended March 31, | ||||||
2019 | 2018 | % Change | ||||
Net sales | $1,297,402 | $930,928 | 39 % | |||
Cost of goods sold | 766,143 | 525,119 | 46 % | |||
Gross profit | 531,259 | 405,809 | 31 % | |||
Research and development expenses | 90,596 | 78,476 | 15 % | |||
Selling and administrative expenses | 213,182 | 142,644 | 49 % | |||
Amortization of acquisition-related intangibles | 47,625 | 9,185 | NMF | |||
Restructuring and other charges, net | 16,174 | 717 | NMF | |||
Gains on sales of fixed assets | (188) | (69) | 172 % | |||
Operating profit | 163,870 | 174,856 | (6)% | |||
Interest expense | 36,572 | 16,595 | 120 % | |||
Other income, net | (7,278) | (576) | NMF | |||
Income before taxes | 134,576 | 158,837 | (15)% | |||
Taxes on income | 23,362 | 29,421 | (21)% | |||
Net income | $ 111,214 | $129,416 | (14)% | |||
Net income attributable to noncontrolling |
2,385 | - | NMF | |||
Net income attributable to IFF | $ 108,829 | $129,416 | (16)% | |||
Net income per share - basic(1) | $ 0.97 | $ 1.63 | ||||
Net income per share - diluted(1) | $ 0.96 | $ 1.63 | ||||
Average shares outstanding | ||||||
Basic | 111,864 | 79,018 | ||||
Diluted | 113,389 | 79,393 | ||||
(1) |
For 2019, net income per share reflects |
|||||
NMF | Not meaningful |
International Flavors & Fragrances Inc. Condensed Consolidated Balance Sheet (Amounts in thousands) (Unaudited) |
||||
March 31, | December 31, | |||
2019 | 2018 | |||
Cash, cash equivalents, and restricted cash | $ 497,129 | $ 648,522 | ||
Receivables | 1,003,965 | 937,765 | ||
Inventories | 1,114,488 | 1,078,537 | ||
Other current assets | 310,243 | 277,036 | ||
Total current assets | 2,925,825 | 2,941,860 | ||
Property, plant and equipment, net | 1,294,029 | 1,241,152 | ||
Goodwill and other intangibles, net | 8,408,177 | 8,417,710 | ||
Other assets | 583,389 | 288,673 | ||
Total assets | $13,211,420 | $ 12,889,395 | ||
Short term borrowings | $ 84,003 | $ 48,642 | ||
Other current liabilities | 1,060,131 | 1,079,669 | ||
Total current liabilities | 1,144,134 | 1,128,311 | ||
Long-term debt | 4,421,430 | 4,504,417 | ||
Non-current liabilities | 1,376,667 | 1,131,487 | ||
Redeemable noncontrolling interests | 114,711 | 81,806 | ||
Shareholders' equity | 6,154,478 | 6,043,374 | ||
Total liabilities and shareholders' equity | $13,211,420 | $ 12,889,395 |
International Flavors & Fragrances Inc. Consolidated Statement of Cash Flows (Amounts in thousands) (Unaudited) |
||||
Three Months Ended |
||||
|
2019 | 2018 | ||
Cash flows from operating activities: | ||||
Net income | $111,214 | $129,416 | ||
Adjustments to reconcile to net cash provided by (used in) operating activities | ||||
Depreciation and amortization | 81,775 | 33,384 | ||
Deferred income taxes | (12,389) | 18,404 | ||
Gains on sale of assets | (188) | (69) | ||
Stock-based compensation | 7,604 | 7,620 | ||
Pension contributions | (3,956) | (4,387) | ||
Litigation settlement | - | (12,969) | ||
Changes in assets and liabilities, net of acquisitions: | ||||
Trade receivables | (55,935) | (61,301) | ||
Inventories | (24,719) | (30,185) | ||
Accounts payable | 8,988 | (8,435) | ||
Accruals for incentive compensation | (36,969) | (36,583) | ||
Other current payables and accrued expenses | (11,321) | (18,540) | ||
Other assets | (9,978) | (26,035) | ||
Other liabilities | (6,894) | (1,715) | ||
Net cash provided by (used in) operating activities | 47,232 | (11,395) | ||
Cash flows from investing activities: | ||||
Cash paid for acquisitions, net of cash received | (33,895) | (22) | ||
Additions to property, plant and equipment | (57,609) | (33,105) | ||
Proceeds from life insurance contracts | 1,890 | - | ||
Maturity of net investment hedges | - | (2,405) | ||
Proceeds from disposal of assets | 3,970 | 293 | ||
Contingent consideration paid | (4,655) | - | ||
Net cash used in investing activities | (90,299) | (35,239) | ||
Cash flows from financing activities: | ||||
Cash dividends paid to shareholders | (77,779) | (54,420) | ||
Increase in revolving credit facility and short term borrowings | 2,895 | 53,688 | ||
Repayments on debt | (36,156) | - | ||
Proceeds from issuance of stock in connection with stock options | 200 | - | ||
Employee withholding taxes paid | (1,339) | (3,266) | ||
Purchase of treasury stock | - | (10,617) | ||
Net cash used in financing activities | (112,179) | (14,615) | ||
Effect of exchange rates changes on cash and cash equivalents | 3,853 | (1,521) | ||
Net change in cash and cash equivalents | (151,393) | (62,770) | ||
Cash and cash equivalents at beginning of year | 648,522 | 368,046 | ||
Cash and cash equivalents at end of period | $497,129 | $305,276 |
International Flavors & Fragrances Inc. Business Unit Performance (Amounts in thousands) (Unaudited) |
||||
Three Months Ended March 31, | ||||
2019 | 2018 | |||
Net Sales | ||||
Taste | $ 444,602 | $ 449,019 | ||
Scent | 488,352 | 481,909 | ||
Frutarom | 364,448 | - | ||
Consolidated | 1,297,402 | 930,928 | ||
Segment Profit | ||||
Taste | 108,455 | 111,564 | ||
Scent | 85,815 | 93,277 | ||
Frutarom | 29,091 | - | ||
Global Expenses | (18,673) | (23,825) | ||
Operational Improvement Initiatives | (406) | (1,026) | ||
Acquisition Related Costs | - | 514 | ||
Integration Related Costs | (14,897) | - | ||
Restructuring and Other Charges, net | (16,174) | (717) | ||
Gains on Sale of Assets | 188 | 69 | ||
FDA Mandated Product Recall | - | (5,000) | ||
Frutarom Acquisition Related Costs | (9,529) | - | ||
Operating profit | 163,870 | 174,856 | ||
Interest Expense | (36,572) | (16,595) | ||
Other income, net | 7,278 | 576 | ||
Income before taxes | $ 134,576 | $ 158,837 | ||
Operating Margin | ||||
Taste | 24.4 % | 24.8 % | ||
Scent | 17.6 % | 19.4 % | ||
Frutarom | 8.0 % | N/A | ||
Consolidated | 12.6 % | 18.8 % |
International Flavors & Fragrances Inc. GAAP to Non-GAAP Reconciliation Foreign Exchange Impact (Unaudited) |
||||
Q1 Taste |
Sales |
Segment |
||
% Change - Reported (GAAP) | -1% | -3% | ||
Currency Impact | 3% | 2% | ||
% Change - Currency Neutral | 2% | -1% | ||
Q1 Scent |
Sales |
Segment |
||
% Change - Reported (GAAP) | 1% | -8% | ||
Currency Impact | 3% | 5% | ||
% Change - Currency Neutral | 4% | -3% |
GAAP to
Non-GAAP Reconciliation
(Amounts in thousands)
(Unaudited)
The following information and schedules provide reconciliation information between reported GAAP amounts and non-GAAP certain adjusted amounts. This information and schedules are not intended as, and should not be viewed as, a substitute for reported GAAP amounts or financial statements of the Company prepared and presented in accordance with GAAP.
Reconciliation of Gross Profit | ||||
First Quarter | ||||
2019 | 2018 | |||
Reported (GAAP) | $ 531,259 | $ 405,809 | ||
Operational Improvement Initiatives (a) | 406 | 453 | ||
Integration Related Costs (c) | 156 | - | ||
FDA Mandated Product Recall (e) | - | 5,000 | ||
Frutarom Acquisition Related Costs (g) | 7,850 | - | ||
Adjusted (Non-GAAP) | $ 539,671 | $ 411,262 | ||
Reconciliation of Selling and Administrative Expenses | ||||
First Quarter | ||||
2019 | 2018 | |||
Reported (GAAP) | $ 213,182 | $ 142,644 | ||
Acquisition Related Costs (b) | - | 514 | ||
Integration Related Costs (c) | (14,557) | - | ||
Frutarom Acquisition Related Costs (g) | (1,679) | - | ||
Adjusted (Non-GAAP) | $ 196,946 | $ 143,158 | ||
Reconciliation of Operating Profit | ||||
First Quarter | ||||
2019 | 2018 | |||
Reported (GAAP) | $ 163,870 | $ 174,856 | ||
Operational Improvement Initiatives (a) | 406 | 1,026 | ||
Acquisition Related Costs (b) | - | (514) | ||
Integration Related Costs (c) | 14,897 | - | ||
Restructuring and Other Charges, net (d) | 16,174 | 717 | ||
Gains on Sale of Assets | (188) | (69) | ||
FDA Mandated Product Recall (e) | - | 5,000 | ||
Frutarom Acquisition Related Costs (g) | 9,529 | - | ||
Adjusted (Non-GAAP) | $ 204,688 | $ 181,016 |
GAAP to
Non-GAAP Reconciliation
(Amounts in thousands)
(Unaudited)
The following information and schedules provide reconciliation information between reported GAAP amounts and non-GAAP certain adjusted amounts. This information and schedules are not intended as, and should not be viewed as, a substitute for reported GAAP amounts or financial statements of the Company prepared and presented in accordance with GAAP.
Reconciliation of Net Income | ||||||||||||||||||
First Quarter | ||||||||||||||||||
2019 | 2018 | |||||||||||||||||
Income before |
Taxes on |
Net Income |
Diluted EPS |
Income before |
Taxes on |
Net Income |
Diluted EPS (j) |
|||||||||||
Reported (GAAP) | $ 134,576 | $ 23,362 | $ 108,829 | $ 0.96 | $ 158,837 | $ 29,421 | $ 129,416 | $ 1.63 | ||||||||||
Operational Improvement Initiatives (a) | 406 | 142 | 264 | - | 1,026 | 294 | 732 | 0.01 | ||||||||||
Acquisition Related Costs (b) | - | - | - | - | (514) | (134) | (380) | - | ||||||||||
Integration Related Costs (c) | 14,897 | 3,349 | 11,548 | 0.10 | - | - | - | - | ||||||||||
Restructuring and Other Charges, net (d) | 16,174 | 4,031 | 12,143 | 0.11 | 717 | 169 | 548 | 0.01 | ||||||||||
Gains on Sale of Assets | (188) | (43) | (145) | - | (69) | (17) | (52) | - | ||||||||||
FDA Mandated Product Recall (e) | - | - | - | - | 5,000 | 1,196 | 3,804 | 0.05 | ||||||||||
U.S. Tax Reform (f) | - | - | - | - | - | (649) | 649 | 0.01 | ||||||||||
Frutarom Acquisition Related Costs (g) | 9,529 | 1,530 | 7,999 | 0.07 | - | - | - | - | ||||||||||
Adjusted (Non-GAAP) | $ 175,394 | $ 32,371 | $ 140,638 | $ 1.24 | $ 164,997 | $ 30,280 | $ 134,717 | $ 1.69 | ||||||||||
Reconciliation of Adjusted (Non-GAAP) EPS ex. Amortization | ||||||||||||||||||
First Quarter | ||||||||||||||||||
Numerator | 2019 | 2018 | ||||||||||||||||
Adjusted (Non-GAAP) Net Income | $ 140,638 | $ 134,717 | ||||||||||||||||
Amortization of Acquisition related Intangible |
47,625 | 9,185 | ||||||||||||||||
Tax impact on Amortization of Acquisition related |
10,196 | 2,336 | ||||||||||||||||
Amortization of Acquisition related Intangible |
37,429 | 6,849 | ||||||||||||||||
Adjusted (Non-GAAP) Net Income ex. |
178,067 | 141,566 | ||||||||||||||||
Denominator | ||||||||||||||||||
Weighted average shares assuming |
113,389 | 79,393 | ||||||||||||||||
Adjusted (Non-GAAP) EPS ex. Amortization | $ 1.57 | $ 1.78 | ||||||||||||||||
(a) | Represents accelerated depreciation related to a plant relocation in India, as well as a lab closure in Taiwan for 2018. | |||||||||||||||||
(b) |
Represents adjustments to the contingent consideration payable for PowderPure, and transaction costs related to Fragrance Resources and PowderPure within Selling and administrative expenses. |
|||||||||||||||||
(c) |
For 2019, represents costs related to the integration of the
Frutarom acquisition, principally advisory services. For 2018,
represents costs related to the integration of the David Michael
and Fragrance |
|||||||||||||||||
(d) | For 2019, represents severance costs related primarily to Scent. For 2018, represents severance costs related to the 2017 Productivity Program and Taiwan lab closure. | |||||||||||||||||
(e) | Represents losses related to the FDA mandated recall. | |||||||||||||||||
(f) | Represents charges incurred related to enactment of certain U.S. tax legislation changes in December 2017. | |||||||||||||||||
(g) |
Represents transaction-related costs and expenses related to the
acquisition of Frutarom. Amount primarily includes $7.9 million of
amortization for inventory "step-up" costs and $1.7 million of |
|||||||||||||||||
(h) |
The income tax expense (benefit) on non-GAAP adjustments is
computed in accordance with ASC 740 using the same methodology as
the GAAP provision of income taxes. Income tax effects of non- |
|||||||||||||||||
(i) | For 2019, net income is reduced by income attributable to noncontrolling interest of $2.4M. | |||||||||||||||||
(j) | The sum of these items does not foot due to rounding. | |||||||||||||||||
(k) | Represents all amortization of intangible assets acquired in connection with acquisitions, net of tax. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20190506005749/en/
Source:
Michael DeVeau
Head of Investor Relations and Communications &
Divisional CFO, Scent
212.708.7164
Michael.DeVeau@iff.com